DOCSLIB.ORG

Micronization by Rapid Expansion of Supercritical Solutions to Enhance the Dissolution Rates of Poorly Water-Soluble Pharmaceuticals

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Micronization by Rapid Expansion of Supercritical Solutions to Enhance the Dissolution Rates of Poorly Water-Soluble Pharmaceuticals 4794 Ind. Eng. Chem. Res. 2000, 39, 4794-4802 Micronization by Rapid Expansion of Supercritical Solutions to Enhance the Dissolution Rates of Poorly Water-Soluble Pharmaceuticals M. Charoenchaitrakool, F. Dehghani, and N. R. Foster* School of Chemical Engineering and Industrial Chemistry, The University of New South Wales, Sydney, Australia, 2052 H. K. Chan Faculty of Pharmacy, The University of Sydney, Sydney, Australia, 2006 The dissolution of a drug into the biological environment can be enhanced by reducing the particle size of the drug. In this study the rapid expansion of supercritical solutions (RESS) process was employed to micronize racemic ibuprofen, and the dissolution rate of the micronized product in a buffered solution was examined. The chiral nonsteroidal antiinflammatory, racemic ibuprofen, was used as a model drug because its dissolution rate is limited by its poor solubility in water. The phase behavior of the ibuprofen-CO2 binary system was investigated prior to the solubility measurements being undertaken. The solubility of racemic ibuprofen in supercritical CO2 was measured using a dynamic apparatus at pressures between 80 and 220 bar and temperatures of 35, 40, and 45 °C. The solubility data was modeled using the Peng-Robinson equation of state with van der Waals mixing rules. The ratio of R and S isomers in the extract was found to be the same as that in the original material. The solubility of pure optical isomers of ibuprofen, namely, (S)-ibuprofen and (R)-ibuprofen, were also determined at 35 °C within the pressure range of 80-200 bar. It was found that (S)-ibuprofen exhibited solubility in CO2 similar to (R)- ibuprofen, and the solubility of the pure isomers was at least 60% higher than that of the racemic ibuprofen at all pressures. The RESS experiments involved studying the effect of spraying distance, the pre-expansion pressure, and nozzle length on the particle size. The median particle size of ibuprofen precipitated by RESS was less than 2.5 µm. Although the particles obtained were aggregated, they were easily dispersed by ultrasonication in water. The pre-expansion pressure and nozzle length had no effect on the particle size and morphology within the range of operating conditions studied. An increase in spraying distance resulted in a slight decrease in particle size and degree of aggregation. The powder dissolution rate of racemic ibuprofen was enhanced as the particle size decreased. The degree of crystallinity of the processed ibuprofen was slightly decreased; as a result, the micronized product exhibited a higher disk intrinsic dissolution rate. The increase in dissolution rate of ibuprofen was hence due to both the reduction in particle size and the degree of crystallinity. Introduction zation of particles. In the RESS process, solutes are dissolved in a supercritical fluid, resulting in a solute- Many drugs exhibit poor solubility in water, and their laden supercritical phase. By reduction of the pressure absorptions in the gastrointestinal tract are limited by across an expansion device, fine particles with a narrow their dissolution rates. In the pharmaceutical industry, size distribution can be obtained. One advantage of micronization techniques are used to improve dissolu- micronization by the RESS process is the ability to tion rates of drugs into the biological environment. produce solvent-free product without the need for ad- Several conventional techniques have been utilized for ditional solvents or surfactants to induce precipitation. particle size reduction. These include mechanical com- Low critical temperature solvents such as CO2 (Tc ) minution (crushing, grinding, and milling), spray-dry- 31.1 °C) can be used for the precipitation of thermally ing, freeze-drying, and recrystallization of the solute labile materials without the risk of degradation. The particles from solutions using liquid antisolvents. The application of RESS can also be extended to the pro- disadvantages of using these conventional techniques cessing of shock and chemically sensitive substances, are thermal and chemical degradation of products, large for the formation of thin films and fibers, for microen- amounts of solvent use and associated disposal prob- capsulation, and for mixing of powders.2 lems, broad particle size distributions, and solvent Ibuprofen is a chiral nonsteroidal antiinflammatory 1 residues. drug (NSAID) of which the (S)-(+)-enantiomer exhibits A novel technique, the rapid expansion of supercritical higher antiinflammatory activity than the (R)-(-) enan- solutions (RESS), was recently developed for microni- tiomer.3 It is most often prescribed to treat arthritis, fever, menstrual symptoms, and pain. The required * To whom correspondence should be addressed. Phone: intakes of ibuprofen can be minimized by improving its 61-2-9385-4341. Fax: 61-2-9385-5966. E-mail: N.Foster@ effectiveness in terms of increasing the dissolution rate unsw.edu.au. in the biological environment. 10.1021/ie000151a CCC: $19.00 © 2000 American Chemical Society Published on Web 12/04/2000 Ind. Eng. Chem. Res., Vol. 39, No. 12, 2000 4795 It is well recognized that the dissolution rate of drugs P is the operating pressure, Φ2 is the solute fugacity in the gastrointestinal fluids is generally the rate- s coefficient, and v2 is the solute molar volume. determining step in the absorption of drugs rather than The Peng-Robinson equation of state (PR EOS) is their diffusion rates across the gut wall. However, the commonly used to evaluate the fugacity coefficient at in vivo dissolution rate and the availability of a drug high pressure.9 The objective of this modeling was to for gastrointestinal absorption from solid dosage forms provide a mathematical description of the measured are difficult to determine. In vitro dissolution rate data, which can be used to interpolate the solubility at experiments are generally performed instead.4 other conditions. In this study, the feasibility of the RESS technique Solute physical properties, such as critical tempera- for the micronization of poorly water-soluble ibuprofen ture (Tc), critical pressure (Pc), and acentric factor (ω), was investigated. Prior to the RESS experiments, an for high molecular weight compounds are not commonly investigation of ibuprofen solubility in supercritical CO2 available. The group contribution techniques such as 10,11 (SC CO2) was required. The solubility of racemic ibu- Joback, Ambrose, and Lydersen have been employed profen in SC CO2 was measured using a dynamic to estimate solute physical properties. The vapor pres- apparatus for pressures between 80 and 220 bar and sure of ibuprofen and its molar volume were estimated temperatures of 35, 40, and 45 °C. The solubility data by the methods presented by Lyman et al.11 The was modeled using the Peng-Robinson equation of state interaction parameter (kij) was assumed to be a function with van der Waals mixing rules. The solubilities of (S)- of temperature and was varied to obtain the best fit of ibuprofen and (R)-ibuprofen were also determined at 35 the experimental data. A PASCAL program was written °C within the pressure range of 80-200 bar. The RESS to optimize kij by minimizing the average absolute experiments involved an investigation of the effects of relative deviation (AARD) using the golden search the pre-expansion pressure, spraying distance, and method.12 The AARD that was used as an objective nozzle length on the size and morphology of the par- function was calculated by the following equation, ticles. The dissolution kinetics of the particles in a phosphate buffered solution were also determined. Two - 1 ypred yexpt different dissolution tests, powder dissolution and disk AARD ) Σ| | (2) intrinsic dissolution, were employed to investigate the N yexpt effect of size reduction and degree of crystallinity on the dissolution kinetics of ibuprofen. where N is the number of experimental data, ypred is Solubility data are essential for an accurate experi- the solubility predicted by the model, and yexpt is the mental design and for calculation of the concentration experimental data. of supercritical solutions at different RESS operating conditions. Solubility data for ibuprofen in SC CO2 at Materials and Methods 50 °C has been reported by Estevez and Suleiman.5 However, no information regarding the phase behavior Materials. Racemic ibuprofen (Sigma, 99.8% purity), (S)-(+)-ibuprofen (Aldrich, 99% purity), (R)-(-)-ibupro- of ibuprofen in CO2 nor solubility data at other iso- therms were reported. fen (RBI, 99% purity) were used as received. Carbon dioxide (BOC Gases, 99.95%) was used as the solvent. McHugh and Krukonis6 found that some solid organ- Phosphate buffer (Sigma, 8.3 mmol/L, pH 7.2) was used ics may exhibit melting-point (or freezing-point) depres- for preparing the mobile phase for HPLC analysis. sions when compressed in the presence of a supercritical fluid (SCF). As the pressure increases, the solubility of Potassium phosphate monobasic (Sigma, 99% purity) the SCF in the solute phase increases, resulting in lower and sodium hydroxide (Sigma, minimum 98% purity) temperatures being required to freeze the solute. The were used to prepare phosphate buffer solution for the degree of melting-point depression is dependent on the dissolution studies. solubility of the SCF in the solute phase. If the solubility Melting-Point Depression Studies. A study of the of the SCF is large, the melting-point depression will melting-point depression of racemic ibuprofen and its be significant. Melting-point depression has been ob- enantiomers was carried out using a static technique. A glass tube (i.d. ) 5 8 mm) loaded with the solute was served in several binary systems, such as CO2- 7 placed inside the view cell (Jerguson sight gauge series naphthalene and CO2-octacosane. In this study, the phase behavior of racemic ibuprofen and its enantiomers No. 32). The system was placed in the constant tem- was examined prior to the solubility measurements perature water bath. Carbon dioxide was gradually fed being conducted. into the view cell at 3 bar increments.
Load more

Recommended publications
  • 4-Aza Steroids As Active Inhibitors of Testosterone
    Europäisches Patentamt *EP000880540B1* (19) European Patent Office Office européen des brevets (11) EP 0 880 540 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.7: C07J 73/00, A61K 31/59 of the grant of the patent: 12.06.2002 Bulletin 2002/24 (86) International application number: PCT/US97/00469 (21) Application number: 97901995.7 (87) International publication number: (22) Date of filing: 09.01.1997 WO 97/30069 (21.08.1997 Gazette 1997/36) (54) 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE 17-BETA-CYCLOPROPYL(AMINO/OXY)4-AZA STEROIDE ALS TESTOSTERONE 5-ALPHA-RECTASE UND C17-20-LYASE HEMMENDE VERBINDUNGEN 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDES UTILISES EN QUALITES D’INHIBITEURS DE 5-ALPHA-REDUCTASE ET DE C17-20-LYASE DE TESTOSTERONE (84) Designated Contracting States: (74) Representative: Minoja, Fabrizio, Dr. et al AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC Bianchetti Bracco Minoja S.r.l. NL PT SE Via Rossini, 8 Designated Extension States: 20122 Milano (IT) AL LT LV RO SI (56) References cited: (30) Priority: 14.02.1996 US 601278 WO-A-93/15104 WO-A-93/23053 WO-A-94/28010 (43) Date of publication of application: 02.12.1998 Bulletin 1998/49 • JOURNAL OF MEDICINAL CHEMISTRY, vol. 38, no. 7, 31 March 1995, WASHINGTON US, pages (73) Proprietor: Aventis Pharmaceuticals Inc. 1158-1173, XP002030536 XUN LI ET AL: Bridgewater, NJ 08807-0800 (US) "Synthesis and in Vitro Activity of 17.beta.-(N-Alkyl/arylformamido)- and (72) Inventors: 17.beta.-[(Alkyl/aryl)alkyl/arylamido]-4-m • PRIBISH, James R.
    [Show full text]
  • A Review on Micronization Techniques JALAY T
    Jalay T. Joshi / Journal of Pharmaceutical Science and Technology Vol. 3 (7), 2011,651-681 A Review on Micronization Techniques JALAY T. JOSHI Department of Pharmaceutics and Pharmaceutical Technology, Sardar Patel University, A. R. College of Pharmacy and G. H. Patel Institute of Pharmacy, Motabazar, Vallabh Vidyanagar-388120, Anand, Gujarat, India Abstract: Drug powders containing micron-size drug particles are used in several pharmaceutical dosage forms. Many drugs, especially newly developed substances, are poorly water soluble, which limits their oral bioavailability. The dissolution rate can be enhanced by using micronized drugs. Small drug particles are also required in administration forms, which require the drug in micron-size size due to geometric reasons in the organ to be targeted (e.g., drugs for pulmonary use). The common technique for the preparation of micron-size drugs is the mechanical commination (e.g., by crushing, grinding, and milling) of previously formed larger particles. In spite of the widespread use of this technique, the milling process does not represent the ideal way for the production of small particles because drug substance properties and surface properties are altered in a mainly uncontrolled manner. Thus, techniques that prepare the drug directly in the required particle size are of interest. Because physicochemical drug powder properties are decisive for the manufacturing of a dosage form and for therapeutic success, the characterization of the particle surface and powder properties plays an important role. This article summarizes common and novel techniques for the production of a drug in small particle size. The properties of the resulting products that are obtained by different techniques are characterized and compared.
    [Show full text]
  • Solubility of Progesterone in Supercritical Carbon Dioxide and Its Micronization Through RESS
    Powder Technology 258 (2014) 66–77 Contents lists available at ScienceDirect Powder Technology journal homepage: www.elsevier.com/locate/powtec Solubility of progesterone in supercritical carbon dioxide and its micronization through RESS Zhen Huang ⁎, Yu-hua Guo, Hui Miao, Li-jun Teng Department of Packaging Engineering, Institute of Materials & Chemical Engineering, Tianjin University of Commerce, Tianjin 300134, China article info abstract Article history: To investigate the formation of progesterone fine particles with rapid expansion of supercritical solution (RESS), Received 16 September 2013 it is vital to determine the solubility of progesterone under various equilibrium pressure and temperature Received in revised form 6 February 2014 conditions and to correlate the solubility data with a well-performed model. In this study, the solubility of Accepted 1 March 2014 progesterone in supercritical CO was measured using a dynamic apparatus at pressure ranging from 120 to Available online 11 March 2014 2 260 bar, and temperature from 313.15 to 338.15 K. The determined solubility in mole fraction is in the range −5– −4 – Keywords: of 5.3 × 10 8.9 × 10 and correlated with three empirical density-based models and the Peng Robinson Progesterone equation of state model. The latter model has better correlation effects than the other density-based models Supercritical CO2 and provides an overall average absolute relative deviation of 11.6% between the calculated and experimental Solubility data correlation solubility. Then, the performances of RESS under different conditions are evaluated by analyzing the particle RESS characteristics, and the effects of extraction temperature, extraction pressure, and nozzle diameter on the particle Particle micronization size and particle size distribution of the formed particles are discussed.
    [Show full text]
  • Overview of the Manufacturing Methods of Solid Dispersion Technology for Improving the Solubility of Poorly Water-Soluble Drugs and Application to Anticancer Drugs
    pharmaceutics Review Overview of the Manufacturing Methods of Solid Dispersion Technology for Improving the Solubility of Poorly Water-Soluble Drugs and Application to Anticancer Drugs Phuong Tran 1, Yong-Chul Pyo 1, Dong-Hyun Kim 1, Sang-Eun Lee 1, Jin-Ki Kim 2,* and Jeong-Sook Park 1,* 1 College of Pharmacy, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Korea; [email protected] (P.T.); [email protected] (Y.-C.P.); [email protected] (D.-H.K.); [email protected] (S.-E.L.) 2 College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, 55 Hanyangdaehak-ro, Sangnok-gu, Ansan 15588, Korea * Correspondence: [email protected] (J.-K.K.); [email protected] (J.-S.P.); Tel.: +82-42-821-5932 (J.-K.K. & J.-S.P.) Received: 12 February 2019; Accepted: 15 March 2019; Published: 19 March 2019 Abstract: Approximately 40% of new chemical entities (NCEs), including anticancer drugs, have been reported as poorly water-soluble compounds. Anticancer drugs are classified into biologic drugs (monoclonal antibodies) and small molecule drugs (nonbiologic anticancer drugs) based on effectiveness and safety profile. Biologic drugs are administered by intravenous (IV) injection due to their large molecular weight, while small molecule drugs are preferentially administered by gastrointestinal route. Even though IV injection is the fastest route of administration and ensures complete bioavailability, this route of administration causes patient inconvenience to visit a hospital for anticancer treatments. In addition, IV administration can cause several side effects such as severe hypersensitivity, myelosuppression, neutropenia, and neurotoxicity. Oral administration is the preferred route for drug delivery due to several advantages such as low cost, pain avoidance, and safety.
    [Show full text]
  • The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug
    pharmaceutics Review The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings Louise Carson 1, Ruth Merkatz 2, Elena Martinelli 2, Peter Boyd 1, Bruce Variano 2 , Teresa Sallent 2 and Robert Karl Malcolm 1,* 1 School of Pharmacy, Queen’s University Belfast, Belfast BT9 7BL, UK; [email protected] (L.C.); [email protected] (P.B.) 2 Population Council, One Dag Hammarskjold Plaza, New York, NY 10017, USA; [email protected] (R.M.); [email protected] (E.M.); [email protected] (B.V.); [email protected] (T.S.) * Correspondence: [email protected] Abstract: The diversity and dynamics of the microbial species populating the human vagina are increasingly understood to play a pivotal role in vaginal health. However, our knowledge about the potential interactions between the vaginal microbiota and vaginally administered drug delivery systems is still rather limited. Several drug-releasing vaginal ring products are currently marketed for hormonal contraception and estrogen replacement therapy, and many others are in preclinical and clinical development for these and other clinical indications. As with all implantable polymeric devices, drug-releasing vaginal rings are subject to surface bacterial adherence and biofilm formation, mostly associated with endogenous microorganisms present in the vagina. Despite more than Citation: Carson, L.; Merkatz, R.; 50 years since the vaginal ring concept was first described, there has been only limited study and Martinelli, E.; Boyd, P.; Variano, B.; reporting around bacterial adherence and biofilm formation on rings. With increasing interest in the Sallent, T.; Malcolm, R.K. The Vaginal vaginal microbiome and vaginal ring technology, this timely review article provides an overview Microbiota, Bacterial Biofilms and of: (i) the vaginal microbiota, (ii) biofilm formation in the human vagina and its potential role in Polymeric Drug-Releasing Vaginal Rings.
    [Show full text]
  • Pharmaceutical Particle Technologies: an Approach to Improve Drug Solubility, Dissolution and Bioavailability
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector asian journal of pharmaceutical sciences 9 (2014) 304e316 HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/ajps/default.asp Review Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability Prakash Khadka a,1, Jieun Ro a,1, Hyeongmin Kim a, Iksoo Kim a, * Jeong Tae Kim a, Hyunil Kim a, Jae Min Cho a, Gyiae Yun b, Jaehwi Lee a, a College of Pharmacy, Chung-Ang University, Seoul 156-756, Republic of Korea b Department of Food Science and Technology, Chung-Ang University, Anseong 456-756, Republic of Korea article info abstract Article history: Pharmaceutical particle technology is employed to improve poor aqueous solubility of drug Received 26 March 2014 compounds that limits in vivo bioavailability owing to their low dissolution rate in the Received in revised form gastrointestinal fluids following oral administration. The particle technology involves 20 May 2014 several approaches from the conventional size reduction processes to the newer, novel Accepted 23 May 2014 particle technologies that modify the solubility properties of the drugs and produce solid, Available online 13 June 2014 powdered form of the drugs that are readily soluble in water and can be easily formulated into various dosage forms. This review highlights the solid particle technologies available for Keywords: improving solubility, dissolution and bioavailability of drugs with poor aqueous solubility. Particle technology © 2014 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. This is Drug solubility an open access article under the CC BY-NC-ND license (http://creativecommons.org/ Poorly water soluble drug licenses/by-nc-nd/3.0/).
    [Show full text]
  • Microencapsulation and Nanoencapsulation Using Supercritical Fluid (SCF) Techniques
    pharmaceutics Review Microencapsulation and Nanoencapsulation Using Supercritical Fluid (SCF) Techniques Soon Hong Soh 1 and Lai Yeng Lee 1,2,* 1 Newcastle Research and Innovation Institute, 80 Jurong East Street 21, #05-04 Devan Nair Institute for Employment & Employability, Singapore 609607, Singapore; [email protected] 2 Newcastle University in Singapore, 537 Clementi Road, #06-01 SIT Building@Ngee Ann Polytechnic, Singapore 599493, Singapore * Correspondence: [email protected]; Tel.: +65-6908-6016 Received: 8 December 2018; Accepted: 27 December 2018; Published: 5 January 2019 Abstract: The unique properties of supercritical fluids, in particular supercritical carbon dioxide (CO2), provide numerous opportunities for the development of processes for pharmaceutical applications. One of the potential applications for pharmaceuticals includes microencapsulation and nanoencapsulation for drug delivery purposes. Supercritical CO2 processes allow the design and control of particle size, as well as drug loading by utilizing the tunable properties of supercritical CO2 at different operating conditions (flow ratio, temperature, pressures, etc.). This review aims to provide a comprehensive overview of the processes and techniques using supercritical fluid processing based on the supercritical properties, the role of supercritical carbon dioxide during the process, and the mechanism of formulation production for each process discussed. The considerations for equipment configurations to achieve the various processes described and the
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,163,699 B2 Besse (45) Date of Patent: Jan
    US007163699B2 (12) United States Patent (10) Patent No.: US 7,163,699 B2 Besse (45) Date of Patent: Jan. 16, 2007 (54) PROGESTIN CO-MICRONIZED WITH A A6IR 9/16 (2006.01) SURFACTANT PHARMACEUTICAL A69/20 (2006.01) COMPOSITION COMPRISING SAME A69/48 (2006.01) METHODS FOR MAKING SAME AND USES (52) U.S. Cl. ...................... 424/489: 424/465; 424/456: THEREOF 424/484 (75) Inventor: Jerome Besse, Listrac Medoc (FR) (58) Field of Classification Search ................ 424/489, (73) Assignee: Laboratories Besins International, 424/465, 484, 456 Paris (FR) See application file for complete search history. (*) Notice: Subject to any disclaimer, the term of this (56) References Cited patent is extended or adjusted under 35 U.S.C. 154(b) by 284 days. U.S. PATENT DOCUMENTS 4,196,188 A 4, 1980 Besins (21) Appl. No.: 10/469,441 4,895,726 A 1/1990 Curtet et al. 6,063,404 A 5/2000 Timpe et al. (22) PCT Filed: Feb. 27, 2002 6,086,916 A 7/2000 Agnus et al. 6,124,358 A 9, 2000 Estanove et al. (86). PCT No.: PCT/FRO2/OO714 FOREIGN PATENT DOCUMENTS S 371 (c)(1), FR 2 775 599 3, 1998 (2), (4) Date: Feb. 10, 2004 WO WO 89.02742 10, 1988 WO WOOO,2897O 11, 1999 (87) PCT Pub. No.: WO02/069978 Primary Examiner Edward J. Webman PCT Pub. Date: Sep. 12, 2002 (74) Attorney, Agent, or Firm—Foley & Lardner LLP (65) Prior Publication Data (57) ABSTRACT US 2004/O131553 A1 Jul. 8, 2004 The invention concerns a progestin co-micronized with a (30) Foreign Application Priority Data Surfactant and a pharmaceutical composition comprising Mar.
    [Show full text]
  • Supercritical Fluid Technology for Solubilization of Poorly Water
    ADMET & DMPK 8(4) (2020) 355-374; doi: http://dx.doi.org/10.5599/admet.811 Open Access : ISSN : 1848-7718 http://www.pub.iapchem.org/ojs/index.php/admet/index Review Supercritical fluid technology for solubilization of poorly water soluble drugs via micro- and naonosized particle generation Shashi Kiran Misra1, Kamla Pathak2* 1University Institute of Pharmacy, CSJM University, Kanpur, 208026, India, Email: [email protected] 2Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences, Saifai, Etawah 206130, India Corresponding author e-mail: [email protected] Received: March 15, 2020; Revised: June 18, 2020; Published: June 29, 2016 Abstract Approximately two-third of the compounds in the pharmaceutical industry were developed through combinatorial chemistry and high throughput screening of particulate solids. Poor solubility and bioavailability of these pharmaceuticals are challenging attributes confronted by a formulator during product development. Hence, substantial efforts have been directed into the research on particle generation techniques. Although the conventional methods, such as crushing or milling and crystallization or precipitation, are still used; supercritical fluid technology introduced in the mid-1980s presents a new method of particle generation. Supercritical fluid processes not only produce micro- and nanoparticles with a narrow size distribution, they are also employed for the microencapsulation, cocrystallization, and surface coating with polymer. Recognized as a green technology, it has emerged as successful variants chiefly as Rapid Expansion of supercritical solutions (RESS), Supercritical anti-solvent (SAS) and Particles from Gas Saturated Solution (PGSS) depending upon type of solvent, solute, antisolvent and nebulization techniques. Being economical and eco-friendly, supercritical fluid technolgy has garnered considerable interest both in academia and industry for modification of physicochemical properties such as particle size, shape, density and ultimately solubility.
    [Show full text]
  • Micronization Processes by Supercritical Fluid Technologies: a Short Review on Process Design (2008-2012)
    Acta Scientiarum http://www.uem.br/acta ISSN printed: 1806-2563 ISSN on-line: 1807-8664 Doi: 10.4025/actascitechnol.v35i4.18819 Micronization processes by supercritical fluid technologies: a short review on process design (2008-2012) Wagner Luiz Priamo1, Irede Dalmolin2, Daiane Lúcia Boschetto3, Natália Mezzomo3, Sandra Regina Salvador Ferreira3 and Jose Vladimir Oliveira3* 1Instituto Federal de Educação, Ciência e Tecnologia do Rio Grande do Sul, Sertão, Rio Grande do Sul, Brazil. 2Faculdade de Engenharia de Alimentos, Universidade Estadual de Campinas, Sao Paulo, Brazil. 3Departamento de Engenharia Química e Engenharia de Alimentos, Universidade Federal de Santa Catarina, Cx. Postal 476, 88040-900, Florianópolis, Santa Cataria, Brazil. *Author for correspondence. E-mail: [email protected] ABSTRACT. Several micronization processes based on supercritical fluids have been developed. These processes can be classified according to the role of the supercritical fluid in the process: solvent, solute or co-solvent, and anti-solvent. Application of supercritical fluids as alternative to traditional micronization methods and the growing demand of the industrial sector for new technologies motivated this review. In this context, the objective of this work was to present the operating principles of the micronization process by means of supercritical fluids and the effects of the main process variables on particles characteristics. The review continues with an update of current experimental data presented in the literature in the period from 2008 to 2012. Keywords: supercritical fluids, micronization process, review. Processos de micronização utilizando tecnologia supercrítica: uma breve revisão sobre projeto de processos (200-2012) RESUMO. Vários processos de micronização baseados na tecnologia supercrítica têm sido desenvolvidos.
    [Show full text]
  • Application of Fluids in Supercritical Conditions in the Polymer Industry
    polymers Review Application of Fluids in Supercritical Conditions in the Polymer Industry Karol Tutek, Anna Masek * , Anna Kosmalska and Stefan Cichosz Institute of Polymer and Dye Technology, Faculty of Chemistry, Lodz University of Technology, Stefanowskiego 12/16, 90-924 Lodz, Poland; [email protected] (K.T.); [email protected] (A.K.); [email protected] (S.C.) * Correspondence: [email protected] Abstract: This article reviews the use of fluids under supercritical conditions in processes related to the modern and innovative polymer industry. The most important processes using supercritical fluids are: extraction, particle formation, micronization, encapsulation, impregnation, polymerization and foaming. This review article briefly describes and characterizes the individual processes, with a focus on extraction, micronization, particle formation and encapsulation. The methods mentioned focus on modifications in the scope of conducting processes in a more ecological manner and showing higher quality efficiency. Nowadays, due to the growing trend of ecological solutions in the chemical industry, we see more and more advanced technological solutions. Less toxic fluids under supercritical conditions can be used as an ecological alternative to organic solvents widely used in the polymer industry. The use of supercritical conditions to conduct these processes creates new opportunities for obtaining materials and products with specialized applications, in particular in the medical, pharmacological, cosmetic and food industries, based on substances of natural sources. The considerations contained in this article are intended to increase the awareness of the need to change Citation: Tutek, K.; Masek, A.; the existing techniques. In particular, the importance of using supercritical fluids in more industrial Kosmalska, A.; Cichosz, S.
    [Show full text]
  • Micronization of Polyethylene Wax in an Extrusion Process Using Supercritical Carbon Dioxide
    Micronization of Polyethylene Wax in an Extrusion Process using Supercritical Carbon Dioxide by Nowrin Raihan Abedin A thesis presented to the University of Waterloo in fulfillment of the thesis requirement for the degree of Master of Applied Science in Chemical Engineering Waterloo, Ontario, Canada, 2011 © Nowrin Raihan Abedin 2011 AUTHOR’S DECLARATION I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public. Nowrin R. Abedin ii ABSTRACT Supercritical fluid technology is a well documented and emergent technology used in many industries today for the formation of micro- and nano- particles. The use of supercritical fluids allows synthesis of various types of particles since their properties can be varied with temperature or pressure, which sequentially can control the physical and chemical properties of the particles produced. Several different processes designed to generate powders and composites using supercritical fluids have been proposed in the past 20 years which can be used to synthesize materials with high performance specifications and unique functionality. In this research work, an extrusion micronization process using supercritical fluid has been proposed. This powder production technique could be a promising alternative to conventional techniques in terms of improvement in product quality as it provides a better control over particle size, morphology and particle size distribution, without degradation or contamination of the product. In addition, as extrusion is globally used for polymer production and processing, particle production by extrusion will allow production and processing in a single process step, eliminating the need for secondary particle production methods.
    [Show full text]